Sharma Mani 4

What Happened

• Sharma Mani, SVP, Group Controller and Head of Global Finance Services, acquired 1 share of AstraZeneca (transaction code A — award/grant) on 2026-06-08.
• The share was recorded at $179.75 (total value ~$180). The acquisition was made pursuant to the issuer's Share Incentive Plan.

Key Details

• Transaction date: 2026-06-08; reported price: $179.75; total value: ~$180.
• Footnote: Price reflects GBP134.54 converted to USD at GBP1.0000 = $1.3360 (rate published by the Fed on 2026-06-05).
• Shares owned after the transaction: not disclosed in the Form 4 filing.
• Filing date: 2026-06-16 (filed 8 days after the transaction; appears to be a late filing).

Context

• This was a small award under the company’s share incentive plan — typically part of routine compensation rather than an independent market purchase or sale. Such grants are common for executives and do not, by themselves, indicate a change in insider sentiment.